UMIN ID: UMIN000001892
Registered date:16/04/2009
Association between genetic polymorphism and adverse events or effectiveness of S-1-based chemotherapy in patients with gastrointestinal cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | gastrointestinal cancer |
| Date of first enrollment | 2009/04/01 |
| Target sample size | 100 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Incidence of adverse events |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. Patients with at least 6 months S-1 free interval if they were re-treated by S-1-based chemotherapy (e.g. recurrence after adjuvant chemotherapy) 2. Patients who were judged ineligible by investigator |
Related Information
| Primary Sponsor | Graduate School of Medicine, Kyoto University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Taiho Pharmaceutical |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Takafumi Nishimura |
| Address | Japan |
| Telephone | |
| nisimura@kuhp.kyoto-u.ac.jp | |
| Affiliation | Kyoto University Hospital Outpatient Oncology Unit |
| scientific contact | |
| Name | Takafumi Nishimura |
| Address | 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan Japan |
| Telephone | |
| Affiliation | Kyoto University Hospital Outpatient Oncology Unit |